NYSE - Delayed Quote • USD
Baxter International Inc. (BAX)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 12 | 16 | 16 |
| Avg. Estimate | 0.61 | 0.67 | 2.9 | 3.23 |
| Low Estimate | 0.59 | 0.63 | 2.85 | 3.11 |
| High Estimate | 0.62 | 0.73 | 2.96 | 3.47 |
| Year Ago EPS | 0.49 | 0.55 | 2.6 | 2.9 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 15 | 15 |
| Avg. Estimate | 3.55B | 3.77B | 15.11B | 15.67B |
| Low Estimate | 3.53B | 3.72B | 15.04B | 15.47B |
| High Estimate | 3.59B | 3.79B | 15.17B | 15.98B |
| Year Ago Sales | 3.6B | 3.71B | 14.81B | 15.11B |
| Sales Growth (year/est) | -1.30% | 1.70% | 2.00% | 3.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.49 | 0.61 | 0.67 | 0.86 |
| EPS Actual | 0.49 | 0.55 | 0.68 | 0.88 |
| Difference | 0 | -0.06 | 0.01 | 0.02 |
| Surprise % | 0.00% | -9.80% | 1.50% | 2.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.61 | 0.67 | 2.9 | 3.23 |
| 7 Days Ago | 0.61 | 0.67 | 2.9 | 3.23 |
| 30 Days Ago | 0.61 | 0.67 | 2.89 | 3.22 |
| 60 Days Ago | 0.61 | 0.68 | 2.89 | 3.23 |
| 90 Days Ago | 0.63 | 0.71 | 2.95 | 3.33 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BAX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 24.50% | -- | -- | 0.80% |
| Next Qtr. | 21.80% | -- | -- | 9.60% |
| Current Year | 11.50% | -- | -- | 4.50% |
| Next Year | 11.40% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 4.07% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -1.76% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 |
| Maintains | B of A Securities: Neutral to Neutral | 3/5/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/12/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 2/9/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 |
| Maintains | JP Morgan: Neutral to Neutral | 10/31/2023 |
Related Tickers
BDX Becton, Dickinson and Company
233.15
+0.40%
HOLX Hologic, Inc.
75.10
+0.24%
TFX Teleflex Incorporated
207.38
-0.44%
ALC Alcon Inc.
78.47
-0.67%
EMBC Embecta Corp.
10.35
+1.07%
BLCO Bausch + Lomb Corporation
14.32
+0.07%
XRAY DENTSPLY SIRONA Inc.
30.44
+0.26%
COO The Cooper Companies, Inc.
90.41
+0.61%
ANGO AngioDynamics, Inc.
6.12
-3.32%
ISRG Intuitive Surgical, Inc.
372.63
-0.41%